Migration Summary - Content

Italian User Network
Italian User Network	Second Quarter 2019
Italian User Network Members Join Europe Interchange Virtually	Second Quarter 2020
It’s a New Day at CDISC
Japan CDISC Coordinating Committee
Japan CDISC Coordinating Committee
Japan CDISC Coordinating Committee Update
Japan CDISC Coordinating Committee Update
Japan CDISC Coordinating Committee Update
Japan Update

FAQ

Displaying 1 - 13 of 13

	FAQ Category
Academic Integrity	Education
Another Community Question	Knowledge Base
Anti-Discrimination Policy	Education
Appropriate Student Behavior	Education
Are there QRS-like instruments for which the collected data would not be stored in the FT, QS, or RS domains?	QRS
CDISC Learner Records	Education
CDISC Learner Records	Education
General CEU Information	Education
General Course Costs and Payment Policies	Education
Learner Record Privacy and Information Security Policy	Education
Successfully Completing a Course	Education
What is included in a QRS Supplement?	QRS
Will companies be allowed to develop/add their custom elements and extend the Foundational Standards?	SHARE

Video

Displaying 1 - 15 of 15

Benefits of Membership and Volunteering	No
CDISC - Brand	No
CDISC’s Impact in Asia	No
Controlled Terminology	No
Impact for Academic Researchers	No
Introduction to ADaM	No
Introduction to SDTM Implementation Guide	No
Introduction to SEND Implementation Guide	No
Regulatory Requirements	No
TAUG	No
Traceability	No
What Are CDASH and the CDASH Model	No
What are SDTM and SDTM Concepts?	No
What is the CDASHIG?	No
Whiteboard	No

Basic Page, Article

Displaying 171 - 173 of 173

News

Displaying 61 - 70 of 70

Testimonials

Displaying 71 - 73 of 73

News Link

Displaying 1 - 45 of 45

CDISC’s New Chief Standards Officer Looks To Improve Standards At “Inflection Point”

Improving Serious Adverse Event (SAE) Reporting In Clinical Trials

A Pragmatic Method for Transforming Clinical Research Data from the Research Electronic Data Capture “REDCap” to Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM): Development and Evaluation of REDCap2SDTM

A pragmatic tool for drug discovery

Accelerating drug development for Alzheimer's disease through the use of data standards

Achieving End-to-End Traceability

Alzheimer's treatments: What's on the horizon?

C-Path, CHDI and CDISC Announce Therapeutic Area User Guide for Huntington’s Disease

CDER Plots Pilot Project to Test CDISC Standard

CDISC launches COVID-19 research standards task force

CDISC Releases Data Management Guidance for COVID-19 Trials

CDISC US Interchange 2019 Keynote Address in Full

CDISC's New 360i Helps Move Trial Design From Manual To Modern

Clinical trials haven’t harnessed the digital revolution — TransCelerate’s latest initiative aims to change that

Clupea, KIT to establish Korea's 1st CDISC standard-based non-clinical big data platform

Cross-Stakeholder Collaboration: Advancing Research Through Common Protocol Templates

Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions

Data Management Landscape is Still Changing, Are We Adapting Fast Enough?

Data Standards and ePRO Systems: A Road Less Travelled?

Data Standards in IDEA-FAST

EMA launches pilot project on analysis of raw data from clinical trials

End-to-end innovation in a regulated environment: applying spectral flow cytometry to clinical sample testing

FDA Binding Guidance: A Pivotal Milestone for CDISC Standards - Applied Clinical Trials

FHIR-to-CDISC Project Seeks to Facilitate Use of EHR Data in Clinical Research

Formedix and CDISC Join Forces to Provide Free Access to Ready-to-Use, CDASH-Compliant eCRFs for Accelerated Clinical Trial Set-Up

Harmonisation of large-scale, heterogeneous individual participant adverse event data from randomised trials of statin therapy

How Standardization Can Be An Innovation In Clinical Outsourcing

How TransCelerate, Microsoft, Accenture, and CDISC are Working to Revolutionize Digital Data Flow

Making Data Speak the Same Language

New CDISC Standards Make Sites’ AE Reporting Easier

Powering Standards With Code: The Role Of Open Source In CDISC 360i

Presenting and Sharing Clinical Data using the eTRIKS Standards Master Tree for tranSMART

SDTM vs CDASH: Why You Need Both!

Sharing and reuse of individual participant data from clinical trials: principles and recommendations

The CDISC Open Rules Engine (CORE): Open-Source Software For Clinical

The Turning Point for Clinical Research: Global Data Standardization

Therapeutic Area Data Standards for Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)

TMF Reference Model Affiliation With CDISC Could Improve TMF Interoperability

TransCelerate BioPharma & CDISC Collaborate on SAE Data Collection Standard

TransCelerate BioPharma Commences Collaborative Development of a Novel Digital Data Flow Solution for Study Start-Up

Use of CDISC Standards for Real-world Data: Expert Perspectives From a Qualitative Delphi Survey

Using a therapeutic area user guide to multiply research investments

Using Health IT Data Standards to Boost Interoperability for Clinical Research

Knowledge Base

Displaying 1 - 57 of 57

A Short History of CDISC and SAS Transport Files	Yes
Are These Findings Just Repeats or Were They Scheduled at Time Points?	Yes
Assessing Causality	Yes
Avoiding SDTM and ADaM Dataset and Variable Name Conflicts	Yes
Can I add this variable to my SDTMIG dataset?	Yes
CDISC ADaM Phases, Periods, and Subperiods: A Case Study	No
CDISC-Annotated CRF Repository in Japanese	Yes
Changing Event Severity	Yes
Concept Maps for a Finding with Increasing Levels of Detail	Yes
Concept Maps for Adverse Events with Increasing Levels of Detail	Yes
Concept Maps for Substance Administration with Increasing Levels of Detail	Yes
Considerations for Using CDISC Standards in Observational Studies	Yes
Controlled Terminology: FAQs	Yes
Country Coding	Yes
Do I have to use the variable labels in the SDTMIG?	Yes
Does QNAM Need to Start with a Domain Code?	Yes
Domain vs. Dataset: What's the Difference?	Yes
Domains are Topic-based, Except When They're Based on Structure	Yes
How Do I Represent a Pre-specified Finding?	Yes
How should I represent whether a physical exam was performed in SDTM?	Yes
Implementation of COVID-19 Pandemic Impact Standards	No
IS Domain Scope Update for the SDTMIG v3.4: A Development History and the Difficulties of Standardizing Complicated Biological Processes	Yes
LOINC and the SDTM	Yes
Making Clinical Data Acquisition Standards Harmonization (CDASH) Electronic Case Report Forms Available on the REDCap Shared Data Instrument Library	No
Making Sense of the Various ADaM Documents	Yes
Oncology Disease Response (RS) Supplements	Yes
Pre-specified Events and Pre-specified Findings	Yes
Providing Review-Ready Results in SDTM	Yes
QA Knowledge Base	No
SDTM and CDASH: Why You Need Both	Yes
SDTM Structure Diagrams	Yes
SDTM Timing Variables for Pre-study Findings	Yes
Sex and Gender	Yes
Special Values: "MULTIPLE" and "OTHER"	Yes
Standardized Lab Units	Yes
Study Subject Site Transfers Example	Yes
Study Subject vs. Experimental Unit	Yes
Subject Visits and COVID-19	Yes
TAUG Examples of SDTM Domains	Yes
Test Academic	No
Test Academic - Masquerade	No
The Magic that Happens between CDASH and SDTM	Yes
Translating CDASH "PRIOR" and "ONGO" to SDTM relative timing variables	Yes
UCUM and CDISC Codelists	Yes
Use of Fast Healthcare Interoperability Resources (FHIR) in the Generation of Real World Evidence (RWE)	Yes
Use of FHIR in Clinical Research: From Electronic Medical Records to Analysis	Yes
Use of HL7 FHIR as eSource to Pre-populate CDASH Case Report Forms using a CDISC ODM API	Yes
Variable Metadata Has Changed in SDTM v2.0. How Does This Affect SDTMIG v3.4?	Yes
What Do We Mean When We Say Provisional?	Yes
When Did That Happen? A Brief Guide to Representing Timing in SDTM.	Yes
When Would I Use ISO8601 Interval Format?	Yes
Where Does My Lab Data Go in SDTMIG v3.4?	Yes
Why "study subject" Instead of "study participant"?	Yes
Why Are Certain SDTM Variables "Not for Use in Human Clinical Trials"?	Yes
Why is an Image like a Specimen?	Yes
Why Not Just Use SNOMED?	Yes
Why Would a Standards Development Organization Make Non-standard Variables Available on their Website?	Yes

Resource

Displaying 41 - 45 of 45

Webinar

Displaying 191 - 194 of 194

Therapeutic Area Version

Displaying 71 - 73 of 73

Standard Version

Displaying 141 - 142 of 142

Company

Displaying 251 - 260 of 415

	Membership Level	Company Address
N-Power Medicine,Inc.	Gold	2221 Broadway, Redwood City, CA 94063 United States
Nanumspace	Gold	Office 211, 20, Geonji-ro, Deokjin-gu Jeonju-si Jeollabuk-do 54907 South Korea
Narrativa	Gold	6121 Sunset Blvd. Los Angeles, CA 90028 United States
National Cancer Center East - Japan	Gold	5-1-1 Tsukiji Chuo-ku, Tokyo 104-0045 Japan
National Cancer Institute	Platinum	9609 Medical Center Drive Rockville, MD 20850 United States
National Institute of Allergy & Infectious Diseases (NIAID)	Platinum	Rockville, Maryland 20852 United States
National Institute of Public Health	Gold	2-3-6 Minami Wako, Saitama 351-0197 Japan
National Library of Medicine	Platinum	Bethesda, Maryland 22101 United States
National Organization for Rare Disorders(NORD)	Gold
Navitas Life Sciences	Platinum	502 Carnegie Center, Suite 100 Princeton, NJ 08540 United States